Diagnamed Holdings Corp. announced a private placement of units at a price of CAD 0.04 for the gross proceeds of a minimum of CAD 400,000 and a maximum of CAD 650,000 on May 15, 2024. Each unit will be comprised of one common share in the capital of the company and one common share purchase warrant of the company.

Each Warrant will entitle the holder thereof to acquire one additional common share at a price of CAD 0.05 for a period of thirty-six (36) months from the closing date of the offering. In connection with the offering, the company will pay finder?s fees of up to 8% of the gross proceeds of the offering and issue finders warrants in an amount equal to up to 8% of the number of units. The transaction is expected to close on or about June 10, 2024.

The closing is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals, including the approval of the Canadian Securities Exchange.